4,796
Views
46
CrossRef citations to date
0
Altmetric
Articles

Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population

ORCID Icon, , , , , , , ORCID Icon, , & show all
Pages 1988-1996 | Received 06 Jul 2020, Accepted 22 Aug 2020, Published online: 17 Sep 2020

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733. doi: 10.1056/NEJMoa2001017
  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
  • Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020 Dec;9(1):313–319. doi: 10.1080/22221751.2020.1725399
  • Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569–1578. doi: 10.1016/S0140-6736(20)31022-9
  • Bonovas S, Piovani D. Compassionate use of remdesivir in Covid-19. N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312
  • Wong YK, Yang J, He Y. Caution and clarity required in the use of chloroquine for COVID-19. Lancet Rheumatol. 2020 May;2(5):e255. doi: 10.1016/S2665-9913(20)30093-X
  • Masters PS, Perlman S. Coronaviridae. Fields virology, sixth edition: 825–858.
  • Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845–1854. doi: 10.1016/S0140-6736(20)31208-3
  • Brain D, Mou H, Zhang L, et al. The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement. bioRxiv. 2020;2020.04.10.036418.
  • Gao Q, Bao L, Mao H, et al. Rapid development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 May 6.
  • Zhang H, Song Z, Yu H, et al. Genome-wide linear B-cell epitopes of enterovirus 71 in a hand, foot and mouth disease (HFMD) population. J Clin Virol. 2018 Aug;105:41–48. doi: 10.1016/j.jcv.2018.06.001
  • Huang M, Ma Q, Liu X, et al. Initiator integrated poly(dimethysiloxane)-based microarray as a tool for revealing the relationship between nonspecific interactions and irreproducibility. Anal Chem. 2015 Jul 21;87(14):7085–7091. doi: 10.1021/acs.analchem.5b00694
  • Zhang R, Yi Z, Wang Y, et al. Isolation of a 2019 novel coronavirus strain from a coronavirus disease 19 patient in Shanghai. J Microbes Infect. 2020;15(1):15–20.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408. doi: 10.1006/meth.2001.1262
  • Corse E, Machamer CE. The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting. J Virol. 2002 Feb;76(3):1273–1284. doi: 10.1128/JVI.76.3.1273-1284.2002
  • Vennema H, Godeke GJ, Rossen JW, et al. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 1996 Apr 15;15(8):2020–2028. doi: 10.1002/j.1460-2075.1996.tb00553.x
  • Poh CM, Carissimo G, Wang B, et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020 Jun 1;11(1):2806. doi: 10.1038/s41467-020-16638-2
  • Forthal DN, Finzi A. Antibody-dependent cellular cytotoxicity in HIV infection. Aids. 2018 Nov 13;32(17):2439–2451. doi: 10.1097/QAD.0000000000002011